Have a feature idea you'd love to see implemented?
Let us know!
TECX Tectonic Therapeutic Inc.
Price (delayed)
$44.89
Market cap
$662.25M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$9.74
Enterprise value
$505.55M
clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare disease.
Highlights
The EPS has surged by 67% year-on-year and by 40% since the previous quarter
TECX's debt has surged by 70% year-on-year but it is down by 13% since the previous quarter
Tectonic Therapeutic's equity has increased by 46% YoY but it has decreased by 10% from the previous quarter
Key stats
What are the main financial stats of TECX
Market
Valuations
Earnings
Shares outstanding
14.75M
Market cap
$662.25M
Enterprise value
$505.55M
Price to earnings (P/E)
N/A
Price to book (P/B)
4.4
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$46.81M
EBITDA
-$44.46M
Free cash flow
-$50.29M
Per share
Balance sheet
Liquidity
EPS
-$9.74
Free cash flow per share
-$3.41
Book value per share
$10.2
Revenue per share
$0
TBVPS
$11.45
Total assets
$168.72M
Total liabilities
$18.36M
Debt
$2.98M
Equity
$150.36M
Working capital
$145.28M
Debt to equity
0.02
Current ratio
9.39
Quick ratio
9.22
Net debt/EBITDA
3.52
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-37.2%
Return on equity
-57.3%
Return on invested capital
N/A
Return on capital employed
-30.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TECX stock price
How has the Tectonic Therapeutic stock price performed over time
Intraday
1.95%
1 week
3.77%
1 month
21.65%
1 year
196.89%
YTD
175.06%
QTD
48.15%
Financial performance
How have Tectonic Therapeutic's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$48.66M
Net income
-$45.98M
Gross margin
N/A
Net margin
N/A
TECX's net income is up by 35% year-on-year but it is down by 20% since the previous quarter
TECX's operating income is up by 32% year-on-year but it is down by 24% since the previous quarter
Growth
What is Tectonic Therapeutic's growth rate over time
Valuation
What is Tectonic Therapeutic stock price valuation
P/E
N/A
P/B
4.4
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 67% year-on-year and by 40% since the previous quarter
Tectonic Therapeutic's equity has increased by 46% YoY but it has decreased by 10% from the previous quarter
Efficiency
How efficient is Tectonic Therapeutic business performance
The return on assets has increased by 43% year-on-year but it has declined by 6% since the previous quarter
Tectonic Therapeutic's ROE has increased by 28% YoY but it has decreased by 2.1% from the previous quarter
Dividends
What is TECX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TECX.
Financial health
How did Tectonic Therapeutic financials performed over time
The total liabilities has soared by 140% YoY but it fell by 33% QoQ
The total assets has surged by 53% year-on-year but it has declined by 13% since the previous quarter
TECX's debt is 98% smaller than its equity
TECX's debt has surged by 70% year-on-year but it is down by 13% since the previous quarter
Tectonic Therapeutic's equity has increased by 46% YoY but it has decreased by 10% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.